260660 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Korea Arlico Pharm Co., Ltd. engages in the provision of development and manufacture of pharmaceutical products. Its products include chlorhexidine, smol, mudis, emmao plus, and acrason cream, eldosin capsule, arlicough, conazine, and mosarin tabs, and others. The company was founded on December 28, 1992 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
260660 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company